Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-06
- 2025-05
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
GI 254023X: A Mechanistic Assay Strategy
2026-09-09
GI 254023X is a selective ADAM10 inhibitor for separating protease engagement from Notch1, endothelial-barrier, and cellular phenotypes. This guide combines product evidence with a decision-focused assay framework inspired by quantitative secretase research.
-
GI 254023X: Assay-Ready ADAM10 Mechanistic Design
2026-09-08
GI 254023X is a selective ADAM10 inhibitor for dissecting substrate shedding, Notch1 signaling, and endothelial barrier biology. This article presents an assay-centered framework that connects proximal cleavage measurements with cellular and functional readouts while clarifying how partial-inhibition logic from neurobiology can inform, but not replace, ADAM10 experiments.
-
Heparin sodium in Nanovesicle Uptake Research
2026-09-08
Heparin sodium combines a validated anticoagulation mechanism with a practical exploratory tool for testing heparan sulfate proteoglycan-dependent nanovesicle uptake. This workflow connects anti-factor Xa and aPTT controls with cell-based studies of Sertoli-cell injury while clearly separating established evidence from hypothesis-generating applications.
-
Dihydroethidium in Bone-Cell Redox Assays
2026-09-07
Dihydroethidium offers a practical route to distinguish intracellular superoxide changes in osteoblast and osteoclast models. This article connects DHE fluorescence chemistry with the mitochondrial and NF-κB framework reported for SZQ-3, helping researchers design more interpretable oxidative stress assays.
-
Nigericin: K+/H+ Ionophore Research Guide
2026-09-07
Nigericin is a potassium/hydrogen ion carrier that perturbs membrane gradients and intracellular pH. The BA1112 product dossier supports controlled research on ion transport, cancer-cell stress, and GSDMD-linked cell death while requiring careful solvent, storage, and evidence interpretation.
-
Reserpine (N1867): Practical Workflow Guide
2026-09-05
Reserpine (N1867) provides a characterized research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. Its water and ethanol insolubility make solvent selection, fresh preparation, storage, and vehicle controls essential; it is for research use only and should not be used for diagnostic, medical, clinical, or veterinary applications.
-
Cisplatin (CDDP) Workflow for Cancer Research
2026-09-04
Cisplatin (CDDP) is a practical DNA-damage benchmark for linking cell viability, apoptosis, stemness, and chemotherapy resistance studies. This workflow shows how to prepare fresh material, build interpretable assays, and translate the KLF7–ITGA2 findings in oral cancer into combination and xenograft experiments.
-
AMG 487 CXCR3 Antagonist: Workflow Guide
2026-09-04
AMG 487 enables controlled dissection of CXCR3-driven chemotaxis, calcium signaling, and macrophage-state transitions. This practical guide connects potency data with assay design, formulation control, and troubleshooting for inflammation and translational biology workflows.
-
ARCA EGFP mRNA for Transfection Workflows
2026-09-03
ARCA EGFP mRNA provides a fast, direct fluorescence readout for comparing delivery conditions, expression kinetics, and lipid nanoparticle performance in mammalian cells. This practical guide connects reporter-based quality control with synthetic mRNA infection-model workflows, including the experimental logic demonstrated in a recent intestinal-cell study.
-
N-octanoyl-L-Homoserine lactone Workflows
2026-09-03
Build controlled C8-HSL experiments that connect bacterial quorum sensing with biofilm behavior, virulence, and host-cell signaling. This guide combines concentration-aware assay design, pathway-resolved cancer models, and practical troubleshooting for infection biology research.
-
Acridine Orange hydrochloride: Practical Guide
2026-09-02
Acridine Orange hydrochloride provides membrane-permeable, differential fluorescence for DNA- and RNA-associated nucleic acid staining in cytochemical, microscopy, and flow-based workflows. It is suitable for cell cycle analysis and apoptosis detection when emission channels, fresh solution preparation, and assay-specific concentration and incubation conditions are validated; it is not intended for non-permeant staining or long-term storage of dye solutions.
-
Phosphatase Inhibition for Translational Research
2026-09-02
Preserving phosphorylation during sample preparation can strengthen mechanistic interpretation, phosphoproteomic analysis, and translational decision-making. This article connects Phosphatase Inhibitor Cocktail 1 with lessons from heterogeneous BET responses in HPV-positive head and neck cancer.
-
GI 254023X: An Assay-First ADAM10 Strategy
2026-09-01
GI 254023X is a selective ADAM10 inhibitor suited to mechanistic studies of sheddase-dependent signaling and endothelial barrier injury. This assay-first guide shows how to connect target engagement with Notch1, Jurkat, VE-cadherin, and toxin-challenge readouts without overstating translational evidence.
-
NPT1-Mediated Renal Transport of Faropenem
2026-09-01
The reference study provided the first molecular evidence that human NPT1, an apical renal inorganic phosphate transporter, also mediates uptake of the organic anion p-aminohippuric acid and several drug-like anions, including faropenem. Its heterologous expression and radiotracer experiments connect NPT1 with renal tubular secretion and offer a mechanistic framework for studying β-lactam disposition, while leaving in vivo clearance and clinical relevance to further investigation.
-
Lenalidomide in Myeloma: A Context-Aware Assay Guide
2026-08-31
Lenalidomide and CC-5013 are examined through a context-aware framework for multiple myeloma research. This guide connects direct tumor effects, immune restoration, angiogenesis, and DOT1L-dependent innate immune priming to practical assay decisions.